147 related articles for article (PubMed ID: 31520927)
21. Corrigendum to "Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents" [Eur. J. Med. Chem. 152 (2018) 148-159].
Ghoshal A; Kumar A; Yugandhar D; Sona C; Kuriakose S; Nagesh K; Rashid M; Singh SK; Wahajuddin M; Yadav PN; Srivastava AK
Eur J Med Chem; 2018 Aug; 156():628-630. PubMed ID: 30031973
[No Abstract] [Full Text] [Related]
22. Corrigendum to "1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma" [Eur. J. Med. Chem. 140 (2017) 84-91].
Liu YM; HuangFu WC; Huang HL; Wu WC; Chen YL; Yen Y; Huang HL; Nien CY; Lai MJ; Pan SL; Liou JP
Eur J Med Chem; 2020 Sep; 202():112633. PubMed ID: 32688164
[No Abstract] [Full Text] [Related]
23. Corrigendum to "Design and synthesis of novel artemisinin hybrids with potent activities against human colorectal cancer cells in vitro and in vivo" [Eur. J. Med. Chem. 182 (2019) 111665].
Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
Eur J Med Chem; 2020 May; 194():112256. PubMed ID: 32220686
[No Abstract] [Full Text] [Related]
24. Corrigendum to <' Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors' [Eur. J. Med. Chem. 211 (2021), 113109].
Alvarez RM; García AB; Riesco-Fagundo C; Martín JI; Varela C; Rodríguez Hergueta A; González Cantalapiedra E; Oyarzabal J; Di Geronimo B; Lorenzo M; Albarrán MI; Cebriá A; Cebrián D; Martínez-González S; Blanco-Aparicio C; Pastor J
Eur J Med Chem; 2021 Nov; 224():113703. PubMed ID: 34284231
[No Abstract] [Full Text] [Related]
25. Corrigendum to "Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease" [Eur. J. Med. Chem. 163 (2019), 307-319. DOI: 10.1016/j.ejmech.2018.11.040].
Tang YW; Shi CJ; Yang HL; Cai P; Liu QH; Yang XL; Kong LY; Wang XB
Eur J Med Chem; 2024 Jun; ():116591. PubMed ID: 38890013
[No Abstract] [Full Text] [Related]
26. Corrigendum to "Synthesis and cytotoxic activity of novel A-ring cleaved ursolic acid derivatives in human non-small cell lung cancer cells" [Eur. J. Med. Chem. 123 (2016) 317-331].
Mendes VIS; Bartholomeusz GA; Ayres M; Gandhi V; Salvador JAR
Eur J Med Chem; 2016 Nov; 124():1004-1005. PubMed ID: 27783971
[No Abstract] [Full Text] [Related]
27. Corrigendum to"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo"[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086].
Ojha R; Nepali K; Chen CH; Chuang KH; Wu TY; Lin TE; Hsu KC; Chao MW; Lai MJ; Lin MH; Huang HL; Chang CD; Pan SL; Chen MC; Liou JP
Eur J Med Chem; 2020 Sep; 201():112404. PubMed ID: 32526554
[No Abstract] [Full Text] [Related]
28. Corrigendum to "Search for new multi-target compounds against Alzheimer's disease among histamine H
Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
Eur J Med Chem; 2020 Nov; 205():112611. PubMed ID: 32791398
[No Abstract] [Full Text] [Related]
29. Corrigendum to "A fluorine scan on the Zn
Zhang B; Liu J; Gao D; Yu X; Wang J; Lei X
Eur J Med Chem; 2020 Jul; 198():112340. PubMed ID: 32371332
[No Abstract] [Full Text] [Related]
30. Corrigendum to <'Synthesis and biological evaluation of 2,6-disubstituted-9H-purine, 2,4-disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d] pyrimidine analogues as novel CHK1 inhibitors' [Eur. J. Med. Chem. 151 (2018) 836-848].
Tian C; Han Z; Li Y; Wang M; Yang J; Wang X; Zhang Z; Liu J
Eur J Med Chem; 2019 Jul; 173():184. PubMed ID: 31003059
[No Abstract] [Full Text] [Related]
31. Corrigendum to "N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression"[Eur. J. Med. Chem. 2020 Jan 1;185:111725].
Mehndiratta S; Lin MH; Wu YW; Chen CH; Wu TY; Chuang KH; Chao MW; Chen YY; Pan SL; Chen MC; Liou JP
Eur J Med Chem; 2020 Aug; 199():112406. PubMed ID: 32408215
[No Abstract] [Full Text] [Related]
32. Corrigendum to "Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis" [Eur. J. Med. Chem 209 (2021) 112942].
Faraji A; Oghabi Bakhshaiesh T; Hasanvand Z; Motahari R; Nazeri E; Boshagh MA; Firoozpour L; Mehrabi H; Khalaj A; Esmaeili R; Foroumadi A
Eur J Med Chem; 2021 Mar; 214():113228. PubMed ID: 33550180
[No Abstract] [Full Text] [Related]
33. Corrigendum to "Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response" [Eur J Med Chem. 192 2020 112158].
Wu WC; Liu YM; Lin MH; Liao YH; Lai MJ; Chuang HY; Hung TY; Chen CH; Liou JP
Eur J Med Chem; 2020 Jun; 196():112329. PubMed ID: 32311605
[No Abstract] [Full Text] [Related]
34. Corrigendum to "Inhibition of influenza virus infection by multivalent pentacyclic triterpene-functionalized per-O-methylated cyclodextrin conjugates" [Eur. J. Med. Chem. 134(2017) 133-139].
Tian Z; Si L; Meng K; Zhou X; Zhang Y; Zhou D; Xiao S
Eur J Med Chem; 2021 Nov; 223():113647. PubMed ID: 34153573
[No Abstract] [Full Text] [Related]
35. Corrigendum to "Discovery of a potent, selective and cell active inhibitor of m6A demethylase ALKBH5" [Eur. J. Med. Chem. 238 (2022) 114446].
Fang Z; Mu B; Liu Y; Guo N; Xiong L; Guo Y; Xia A; Zhang R; Zhang H; Yao R; Fan Y; Li L; Yang S; Xiang R
Eur J Med Chem; 2023 Jul; 255():115368. PubMed ID: 37119665
[No Abstract] [Full Text] [Related]
36. Corrigendum to "Synthesis and evaluation of 2,5-furan, 2,5-thiophene and 3,4-thiophene-based derivatives as CXCR4 inhibitors" [Eur. J. Med. Chem. 181 (2019) 111562].
Gaines T; Garcia F; Virani S; Liang Z; Yoon Y; Oum YH; Shim H; Mooring SR
Eur J Med Chem; 2023 Dec; 261():115753. PubMed ID: 37634992
[No Abstract] [Full Text] [Related]
37. Corrigendum to "Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia" [Eur. J. Med. Chem. 221 (2021) 113522].
Ge H; Zhang W; Yuan K; Xue H; Cheng H; Chen W; Xie Y; Zhang J; Xu X; Yang P
Eur J Med Chem; 2022 Jan; 228():114041. PubMed ID: 34902733
[No Abstract] [Full Text] [Related]
38. Corrigendum to "Synthesis of a series of novel dihydroartemisinin monomers and dimers containing chalcone as a linker and their anticancer activity" [Eur. J. Med. Chem. 122 (2016) 232-246].
Gaura R; Pathania AS; Malik FA; Bhakuni RS; Verma RK
Eur J Med Chem; 2022 May; 235():114277. PubMed ID: 35344906
[No Abstract] [Full Text] [Related]
39. Corrigendum to "Design and synthesis of highly TRAIL expression HDAC inhibitors based on ONC201 to promote apoptosis of colorectal cancer" [Eur. J. Med. Chem. 238 (2022) 1-20/114484].
Cui H; Hu Z; Yang K; Huang J; Wu Y; Chen Q; Wei R; Wang P; Wang H; Li H; Chen Y; Lu T; Yao Y; Zhu Y
Eur J Med Chem; 2022 Oct; 240():114568. PubMed ID: 35809536
[No Abstract] [Full Text] [Related]
40. Corrigendum to "Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia" [Eur. J. Med. Chem. 238 (2022) 114479].
Su K; Li Z; Zhang L; Fang S; Mao M; Sun Z; Zhang X
Eur J Med Chem; 2023 Nov; 259():115692. PubMed ID: 37550158
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
